New combination chemo aims to improve surgery in pancreatic cancer

CANCER DIGEST – June 15, 2019 – Researchers at West Virginia University have found

a promising new combination chemotherapy improved survival for patients with pancreatic cancer. Their findings appear in the Journal of the National Cancer Institute.

New imaging agent is able to identify 30 types of cancers

⁶⁸Ga-FAPI PET/CT in patients reflecting
15 different tumor entities. Image Credit:
Kratochwil, Flechhsig, Lindner, et al

CANCER DIGEST – June 8, 2019 – A new imaging agent has been shown to be highly effective in identifying nearly 30 types of malignant tumors, according to a new study published in the Journal of Nuclear Medicine. The agent could be effective in providing physicians with a more complete picture of a patient’s cancer. 

The agent called 68Ga-FPI is used in positron emission tomography/computed tomography or PET/CT and targets cancer-associated fibroblasts and is taken up by a wide variety of tumors in very high amounts, making them clearly stand out on an image study.